By Iain Gilbert
Date: Thursday 08 Feb 2024
(Sharecast News) - Life sciences investor Syncona said on Thursday that its net asset value had grown in the three months ended 31 December, driven by a prioritisation of capital allocation across its portfolio to enable the delivery of key inflection points.
By Josh White
Date: Thursday 16 Nov 2023
(Sharecast News) - Life science specialist Syncona reported a net asset value of £1.2bn at the end of its first half on Thursday, down from £1.25bn on 31 March, with a net asset value return of -4.2% during the period.
By Frank Prenesti
Date: Monday 11 Sep 2023
(Sharecast News) - Syncona shares fell as the UK healthcare investment firm said Novartis had stopped the development of experimental eye treatment, GT005, resulting in milestone payments write-off of £54.5m for Gyroscope Holdings in which Syncona once held a 54% stake.
Currency | UK Pounds |
Share Price | 120.40p |
Change Today | -1.60p |
% Change | -1.31 % |
52 Week High | 162.20 |
52 Week Low | 106.20 |
Volume | 189,531 |
Shares Issued | 652.48m |
Market Cap | £785.58m |
Beta | 0.03 |
RiskGrade | 291 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 21-Jun-18 | 20-Jul-17 |
Paid | 30-Jul-18 | 23-Aug-17 |
Amount | 2.30p | 2.30p |
Time | Volume / Share Price |
12:34 | 2 @ 120.40p |
12:34 | 2 @ 120.40p |
12:34 | 2 @ 120.40p |
12:33 | 2 @ 120.40p |
12:26 | 66 @ 121.80p |
You are here: research